D. Pim

4.3k citations

23 papers · 3.8k indexed · 2 hit papers · h-index 20

Impact in

Oncology top 1%
- Cancer-related Molecular Pathways
- Polyomavirus and related diseases
Biotechnology top 0.5%
- Cancer Research and Treatments

Papers in ⓘ

Oncology 15
- Cancer-related Molecular Pathways 10
- Polyomavirus and related diseases 3
- Cytokine Signaling Pathways and Interactions 2
Genetics 9
- Virus-based gene therapy research 9

Co-authors: L.V. Crawford (9 shared papers)Ed Harlow (2 shared papers)Lawrence Banks (12 shared papers)L. Crawford (5 shared papers)Greg Matlashewski (7 shared papers)R.D. Bulbrook (1 shared paper)Peter Lamb (3 shared papers)Samuel Benchimol (2 shared papers)
Journals: The EMBO Journal (4 papers)Journal of General Virology (3 papers)Oncogene (2 papers)Journal of Virology (2 papers)Molecular and Cellular Biology (2 papers)
Partner nations: Italy United Kingdom Canada

In The Last Decade

D. Pim

23 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer 1982 · 377 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1982 International Journal of Cancer
1981 Journal of Virology

Peers

Countries citing papers authored by D. Pim

Since Specialization

Citations

This map shows the geographic impact of D. Pim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Pim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Pim more than expected).

Fields of papers citing papers by D. Pim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Pim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Pim. The network helps show where D. Pim may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Pim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Pim Line = papers co-authored together D. Pim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Monoclonal antibodies specific for simian virus 40 tumor antigens Journal of Virology ·Ed Harlow, L.V. Crawford, D. Pim, Nicola M. Williamson Hit paper breakdown →	1981	1064
2	Primary structure polymorphism at amino acid residue 72 of human p53. Molecular and Cellular Biology ·Greg Matlashewski, Simon Tuck, D. Pim, Peter Lamb, Johannes Schneider, L.V. Crawford	1987	406
3	Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer International Journal of Cancer ·L.V. Crawford, D. Pim, R.D. Bulbrook Hit paper breakdown →	1982	377
4	Comparison of the in vitro transforming activities of human papillomavirus types. The EMBO Journal ·Alan Storey, D. Pim, Anne M. Murray, K. Osborn, Lawrence Banks, L. Crawford	1988	273
5	Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. The EMBO Journal ·Greg Matlashewski, Peter Lamb, D. Pim, Jim Peacock, L. Crawford, Samuel Benchimol	1984	225
6	Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein. Proceedings of the National Academy of Sciences ·L.V. Crawford, D. Pim, E G Gurney, P.N. Goodfellow, Joyce Taylor‐Papadimitriou	1981	196
7	Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. PubMed ·D. Pim, Mary Collins, Lawrence Banks	1992	190
8	Radioimmunoassay of the cellular protein p53 in mouse and human cell lines. The EMBO Journal ·Samuel Benchimol, D. Pim, L. Crawford	1982	148
9	Human papillomaviruses, cervical cancer and cell polarity Oncogene ·Miranda Thomas, Nisha Narayan, D. Pim, Vjekoslav Tomaić, Paola Massimi, Kazunori Nagasaka, Christian Kranjec, Noor Gammoh, Lawrence Banks	2008	141
10	Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. The EMBO Journal ·Véronique Bouvard, Alan Storey, D. Pim, Lawrence Banks	1994	139
11	Complex of simian virus 40 large-T antigen and host 53,000-molecular-weight protein in monkey cells Journal of Virology ·Ed Harlow, D. Pim, L.V. Crawford	1981	105
12	The cellular protein p53 in human tumours. PubMed ·L.V. Crawford, D. Pim, Patricia W. Lamb	1984	88
13	Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity. Journal of General Virology ·Paola Massimi, D. Pim, Lawrence Banks	1997	73
14	The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction Oncogene ·Kazunori Nagasaka, D. Pim, Paola Massimi, Miranda Thomas, Vjekoslav Tomaić, (unknown), Christian Kranjec, Shunsuke Nakagawa, T. Yano, Y. Taketani, Michael P. Myers, Lawrence Banks	2010	62
15	Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. PubMed ·Miranda Thomas, Gregory J. Matlashewski, D. Pim, Lawrence Banks	1996	58
16	Primary Structure Polymorphism at Amino Acid Residue 72 of Human p53 Molecular and Cellular Biology ·Greg Matlashewski, Simon Tuck, D. Pim, Peter Lamb, Johannes Schneider, L.V. Crawford	1987	56
17	DNA damage induced p53 mediated transcription is inhibited by human papillomavirus type 18 E6. PubMed ·Zhengming Gu, D. Pim, Sylvie Labrecque, Lawrence Banks, Greg Matlashewski	1994	38
18	Characterization of the Complex between SV40 Large T Antigen and the 53K Host Protein in Transformed Mouse Cells Cold Spring Harbor Symposia on Quantitative Biology ·L.V. Crawford, David P. Lane, David T. Denhardt, E. E. Harlow, P. M. Nicklin, K. Osborn, D. Pim	1980	28
19	Expression of Human Papillomavirus Type 6 and Type 16 Capsid Proteins in Bacteria and Their Antigenic Characterization Journal of General Virology ·Lawrence Banks, Greg Matlashewski, D. Pim, Mark J. Churcher, Cyril Sebastian Roberts, L. Crawford	1987	27
20	An immunochemical investigation of SV40 T-antigens 2. Quantitation of antigens and antibody activities Virology ·L.V. Crawford, D. Pim, David P. Lane	1980	23

About D. Pim

D. Pim is a scholar working on Oncology, Genetics, Epidemiology, Biotechnology and Animal Science and Zoology, having authored 23 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Cervical Cancer and HPV Research (10 papers), Virus-based gene therapy research (9 papers), Polyomavirus and related diseases (3 papers), T-cell and Retrovirus Studies (3 papers), RNA modifications and cancer (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Oncology (2.2k citations), Biotechnology (550 citations), Genetics (1.1k citations), Cancer Research (438 citations) and Epidemiology (891 citations). D. Pim has collaborated with scholars based in Italy, United Kingdom and Canada. Frequent co-authors include L.V. Crawford, Ed Harlow, Lawrence Banks, L. Crawford, Greg Matlashewski, R.D. Bulbrook, Peter Lamb, Samuel Benchimol, Alan Storey and Simon Tuck. Their work appears in journals such as The EMBO Journal, Journal of General Virology, Oncogene, Journal of Virology and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact